Skip to main navigation
Skip to search
Skip to main content
Prinses Máxima Centrum Home
Nederlands
English
Search content at Prinses Máxima Centrum
Home
Profiles
Research Groups
Equipment
Research output
Prizes
Activities
Press/Media
How to position pasireotide LAR treatment in acromegaly
Eva C. Coopmans
, Ammar Muhammad
, Aart J. Van Der Lely
, Joseph A.M.J.L. Janssen
,
Sebastian J.C.M.M. Neggers
Research output
:
Contribution to journal
›
Review article
›
peer-review
50
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'How to position pasireotide LAR treatment in acromegaly'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Blood Glucose Monitoring
7%
Clinical Papers
7%
Co-receptor
7%
Combination Studies
7%
Combination Therapy
15%
Consensus Criteria
30%
Evidence Acquisition
7%
Headache
7%
Hyperglycemia
15%
International Journals
7%
Intolerant
7%
Liberal
7%
Long-term Release
100%
Medical Treatment
7%
Monotherapy
23%
Pasireotide
100%
Patient with Tumor
7%
Pegvisomant
46%
Release Treatment
100%
Second-line Therapy
7%
Somatostatin
7%
Somatostatin Receptor Ligands
23%
Third-line Treatment
7%
Tumor Growth
23%
Without Diabetes
7%
Young Patients
7%
Medicine and Dentistry
Acromegaly
100%
Blood Glucose Monitoring
7%
Combination Therapy
15%
Diabetes
7%
Headache
7%
Hyperglycemia
15%
Monotherapy
23%
Pasireotide
100%
Pegvisomant
46%
Side Effect
7%
Somatostatin
7%
Somatostatin Receptor
23%
Tumor Progression
23%
Pharmacology, Toxicology and Pharmaceutical Science
Acromegaly
100%
Combination Therapy
15%
Glucose
7%
Headache
7%
Hyperglycemia
15%
Monotherapy
23%
Pasireotide
100%
Pegvisomant
46%
Side Effect
7%
Somatostatin
7%
Somatostatin Receptor
23%
Tumor Growth
23%